In line with our finding pertaining ALDH expression in CRC tumors our analysis indicated that tumor samples expressing p53 missense mutations tend to exhibit higher levels of CD44 (Supplementary Figure 11). This evidence concerns the gene TP53 and colorectal carcinoma.